Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in aetiology of intracerebral haemorrhage and associated small vessel disease patterns.

European stroke journalยท2026
Same author

HERMES-24 score for outcome prediction in large vessel occlusion stroke: Real-world data from the Austrian stroke network.

International journal of stroke : official journal of the International Stroke Societyยท2026
Same author

The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.

Journal of neurologyยท2026
Same author

An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRI.

Neuroradiologyยท2026
Same author

Functional connectivity dynamics of monoaminergic circuits related to fatigue in multiple sclerosis.

Journal of neurologyยท2026
Same author

Psychosis after weight loss during continuous subcutaneous foslevodopa/foscarbidopa therapy - a case series.

Journal of movement disordersยท2026

Related Experiment Video

Updated: May 15, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Quantitative susceptibility mapping in multiple sclerosis.

Christian Langkammer1, Tian Liu, Michael Khalil

  • 1Department of Neurology, Medical University of Graz, Auenbruggerplatz 22, 8036 Graz, Austria. christian.langkammer@medunigraz.at

Radiology
|January 15, 2013
PubMed
Summary

Quantitative susceptibility mapping (QSM) detects early basal ganglia changes in multiple sclerosis (MS) and clinically isolated syndrome (CIS) more effectively than R2* mapping. QSM shows promise for early MS diagnosis and monitoring disease progression.

More Related Videos

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Related Experiment Videos

Last Updated: May 15, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system.
  • Basal ganglia are key structures affected in MS, but sensitive imaging biomarkers are needed.
  • Quantitative susceptibility mapping (QSM) and R2* mapping are MRI techniques sensitive to tissue magnetic properties.

Purpose of the Study:

  • To compare the sensitivity of QSM and R2* mapping in detecting basal ganglia abnormalities in MS.
  • To correlate QSM findings with clinical and morphologic measures of disease severity in MS patients.
  • To evaluate QSM's potential for early detection of MS-related changes.

Main Methods:

  • Sixty-eight MS patients (including clinically isolated syndrome) and 23 controls underwent 3-T MRI.
  • Susceptibility and R2* maps were reconstructed from multiecho gradient-echo sequences.
  • Mean susceptibilities and R2* rates in the basal ganglia were analyzed and correlated with clinical/morphologic data.

Main Results:

  • QSM revealed significantly increased magnetic susceptibility in the basal ganglia of MS and CIS patients compared to controls.
  • QSM was more sensitive than R2* mapping in detecting group differences.
  • Increased susceptibility correlated with greater neurologic deficits and lower gray matter/cortical volumes.

Conclusions:

  • QSM is a more sensitive technique than R2* mapping for detecting MS-related basal ganglia changes.
  • QSM identified abnormalities even in patients with clinically isolated syndrome, suggesting its utility in early disease stages.
  • QSM may serve as a valuable tool for early MS diagnosis and assessing disease severity.